Curr Opin Neurol2004 Aug;17(4):417-23
The National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.
PURPOSE OF REVIEW: Marked olfactory dysfunction (hyposmia) is a frequent and early abnormality in Parkinson’s disease. We review recent advances related to its cause and its clinical relevance with respect to the differential diagnosis of Parkinsonian syndromes.
RECENT FINDINGS: Marked olfactory dysfunction occurs in Parkinson’s disease and dementia with Lewy bodies but is not found in progressive supranuclear palsy and corticobasal degeneration. In multiple system atrophy, the deficit is mild and indistinguishablefrom cerebellar syndromes of other aetiologies, including the spino-cerebellar ataxias. This is in keeping with evidence of cerebellar involvement in olfactory processing, which may also help to explain recent findings of mild olfactory dysfunction in essential tremor. Smell testing remains, however, a clinically relevant tool in the differential diagnosis of indeterminate tremors. Intact olfaction has also been reported recently in Parkinson’sdisease (PARK 2) and vascular Parkinsonism. The relevance of sniffingability tool faction and a possible role of increased tyrosine hydroxylase and dopamine parts of the olfactory bulb are issues of current interest with respect to the physiology. The early or ‘pre clinical’ detection of Parkinson’s disease is increasingly recognized as an area in which olfactory testing may be of value.
SUMMARY: Research findings have confirmed a rolefor olfactory testing in the differential diagnosis of movement disorders, and suggest that this approach is currently under used in clinical practice. Validated test batteries are now available that may prove to be of practical use in the differential diagnosis of Parkinsonian syndromes and indeterminate tremors.
© SOTO-USA 2025 - All rights are reserved by SOTO-USA to the electronically printed material herein.
This SOT Literature Page and all its contents herein are published by SOTO-USA solely for the purpose of education. All rights reserved by SOTO-USA to accept, reject or modify any submission for publication. The opinions stated in the electronically printed material herein are those of the authors and do not necessarily represent the opinions of SOTO-USA or other individuals associated with SOTO-USA. SOTO-USA does not guarantee or make any representation that the printed material contained herein is valid, reliable or accurate. SOTO-USA does not assume any responsibility for injury arising from any use or misuse of the printed material herein. The printed material contained herein is assumed to be from reliable sources and there is no implication that the printed material herein present the only, or the best methodologies or procedures for the care or treatment of conditions discussed. It is incumbent upon the reader to verify the accuracy of any diagnosis and treatment information contained herein, and to make modifications as new information and/or research arises.
Vist the wisdom, skill, and humor of Dr. DeJarnette the developer of Sacro Occipital Technique.
Major Bertrand DeJarnette, DC, was a renowned inventor, engineer, osteopath, and chiropractor throughout his long and productive career.